Back

Association of Human Cytomegalovirus exposure with tuberculosis disease in South African adults with presumptive tuberculosis

Semugenze, D.; Chiwaya, A.; Kasule, G. W.; Sserubiri, J.; Nabatanzi, R.; Reeve, B. W. P.; Palmer, Z.; Mishra, H.; Katamba, A.; Garcia-Basteiro, A.; Joloba, M. L.; Theron, G.; Cobelens, F.; Ssengooba, W.

2026-02-04 infectious diseases
10.64898/2026.02.02.26345431 medRxiv
Show abstract

Recent studies suggested that human cytomegalovirus (HCMV) exposure may increase tuberculosis (TB) disease risk. We assessed the association between active HCMV infection and recent HCMV exposure with tuberculosis (TB) disease among TB-presumptive South African adults. This was a nested case-control analysis that utilized stored plasma and serum samples collected from adults ([≥]18 years) with presumptive TB self-presenting to primary care clinics in in the Kraaifontein District in Cape Town, South Africa. Cases (n=98) and HIV status frequency matched controls (n=199) basing on mycobacterial culture and or GeneXpert Ultra were included in the study. HCMV DNAemia was detected by qPCR well as current HCMV reactivation or reinfection and recent HCMV infection, reactivation or reinfection were categorized using PCR and serology (IgM and IgG avidity ELISA) results. The median age of all participants was 37 years (IQR 29-47), 164 (55.2%) were male and 119 (40.1%) had previous TB treatment. Overall, 21 (7.1%) had HCMV DNAemia, 19 (6.4%) had positive HCMV IgM and 2 (0.7%) had low HCMV avidity. In a logistic regression model adjusting for age, gender, HIV status and BMI, TB disease was associated with current HCMV reactivation or reinfection [adjusted odds ratio (aOR) 4.88, 95%CI 1.59-16.31, p=0.007]. There was no association with recent HCMV infection, reactivation or reinfection. Unlike recent HCMV infection, reactivation or reinfection, active HCMV replication although not frequent was associated with TB disease which suggests that TB disease or an underlying common factor reactivates HCMV replication in this population.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Clinical Infectious Diseases
231 papers in training set
Top 0.3%
10.6%
2
PLOS ONE
4510 papers in training set
Top 18%
10.2%
3
International Journal of Infectious Diseases
126 papers in training set
Top 0.1%
7.3%
4
The Journal of Infectious Diseases
182 papers in training set
Top 0.4%
6.5%
5
BMC Infectious Diseases
118 papers in training set
Top 0.3%
6.4%
6
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 0.6%
4.9%
7
Open Forum Infectious Diseases
134 papers in training set
Top 0.3%
4.0%
8
Epidemiology and Infection
84 papers in training set
Top 0.4%
4.0%
50% of probability mass above
9
Scientific Reports
3102 papers in training set
Top 35%
3.6%
10
Emerging Infectious Diseases
103 papers in training set
Top 0.7%
3.1%
11
Journal of Infection
71 papers in training set
Top 0.6%
2.8%
12
Tuberculosis
11 papers in training set
Top 0.1%
2.1%
13
PLOS Global Public Health
293 papers in training set
Top 3%
1.8%
14
Thorax
32 papers in training set
Top 0.4%
1.7%
15
Infectious Diseases
14 papers in training set
Top 0.1%
1.7%
16
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.7%
17
European Respiratory Journal
54 papers in training set
Top 1%
1.5%
18
EBioMedicine
39 papers in training set
Top 0.5%
1.3%
19
Clinical Microbiology and Infection
60 papers in training set
Top 0.9%
1.0%
20
Frontiers in Immunology
586 papers in training set
Top 6%
1.0%
21
Frontiers in Medicine
113 papers in training set
Top 6%
0.9%
22
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 4%
0.8%
23
PLOS Pathogens
721 papers in training set
Top 9%
0.8%
24
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.9%
0.8%
25
Pathogens
53 papers in training set
Top 2%
0.7%
26
Journal of Fungi
31 papers in training set
Top 0.6%
0.7%
27
Frontiers in Microbiology
375 papers in training set
Top 9%
0.7%
28
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.7%
29
Vaccines
196 papers in training set
Top 3%
0.7%
30
The Lancet Microbe
43 papers in training set
Top 1%
0.7%